Navegar por autor "Varela Ferreiro, Silvia"

Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study

2013- Firvida Perez, Jose Luis; Lazaro Quintela, Martín; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; [et al.]

Biweekly docetaxel-cisplatin in chemonaive patients with advanced epidermoid carcinoma of the lung - A phase II study of galician lung cancer group

2011- Afonso Afonso, Francisco Javier; Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia

Clinical and epidemiological characteristics of women with breast cancer and aromatase inhibitors treatment who presented hip fracture between 2008-2010

2013- García Porrúa, Carlos; Varela Ferreiro, Silvia; Pacin Cebral, Marta; Miguel Carrera, Jonatan; Lopez Silva, Laura [et al.]

Concurrent chemoradiation for stage III non-small cell lung cancer (NSCLC): A phase II study from the Galician lung cancer group

2013- Pena Álvarez, Carolina; Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; Varela Ferreiro, Silvia; Campos Balea, Begoña [et al.]

Docetaxel (D) and cisplatin (C) induction chemotherapy followed by biweekly D and C with concurrent thoracic radiotherapy for stage iii nonsmall cell lung cancer (NSCLC). A galician lung cancer group study.

2011- Lazaro Quintela, Martín; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; Casal Rubio, Joaquín [et al.]

Efficacy and safety of pemetrexed-cisplatin for advanced non-squamous non-small cell lung cancer - A galician lung cancer group study

2011- Afonso Afonso, Francisco Javier; Firvida Perez, Jose Luis; Varela Ferreiro, Silvia; Campos Balea, Begoña; Barón Duarte, Francisco Javier [et al.]

Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)

2020- Rubio, M.J.; Lecumberri, M.J.; Varela Ferreiro, Silvia; Alarcón, J.; Ortega, M.E.; [et al.]

Erlotinib as frontline treatment for elderly patients (p) with advanced non-squamous non-small cell lung cancer (nsnsclc): ggcp044/09 study

2012- Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña

Erlotinib as frontline treatment for elderly patients (P) with advanced non-squamous non-small cell lung cancer (NSNSCLC): GGCP044/09 study

2012- Afonso Afonso, Francisco Javier; Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; Areses Manrique, María Carmen; Fernández Montes, Ana; [et al.]

Erlotinib as frontline treatment for elderly patients (p) with advanced nonsquamous non-small cell lung cancer (nsNSCLC): GGCP044/09 study

2012- Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; Álvarez Gómez, Elena; Mel Lorenzo, José Ramón [et al.]

Erlotinib as frontline treatment for elderly patients with advanced non-small-cell lung cancer (NSCLC) and non-squamous histology - Results of a galician lung cancer group (GGCP044/09 study) grupo galego de cancro de pulmon (GGCP)

2011- Firvida Perez, Jose Luis; Fernández Montes, Ana; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; [et al.]

Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)

2011- Fernández Calvo, Ovidio; García Mata, Jesús; Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; [et al.]

Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention

2017-09- Cueva Bañuelos, Juan Fernando; Antolín Novoa, Silvia; Calvo Martínez, Lourdes; Fernández, I; Ramos, M; [et al.]

Gemcitabine and Capecitabine as Third- or Later-line Therapy for Refractory Advanced Colorectal Cancer: A Retrospective Study

2013- Valladares Ayerbes, Manuel; Reboredo Lopez, Margarita; Fernández Montes, Ana; Varela Ferreiro, Silvia; Quintero Aldana, Guillermo; [et al.]

Gemcitabine Plus Oral Vinorelbine as Salvage Therapy Treatment for Patients With Advanced Non-small-cell Lung Cancer and Squamous Histology - a Galician Lung Cancer Group Study (GGCP042/09) Grupo Galego De Cancro De Pulmon (GGCP)

2011- Firvida Perez, Jose Luis; Fernández Montes, Ana; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; [et al.]

GGCP041/09: A GALICIAN STUDY OF SECOND-LINE ERLOTINIB IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC

2012- Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; [et al.]

GGCP041/09: A Galician study of second-line erlotinib in patients with advanced non-squamous non-small cell lung cancer (nsNSCLC)

2012- Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; [et al.]

Induction chemotherapy with docetaxel (D) and cisplatin (C) followed by concurrent thoracic radiotherapy with biweekly d and C for stage III non-small cell lung cancer (NSCLC) - A galician lung cancer group study

2011- Anido Herranz, Urbano; Firvida Perez, Jose Luis; Lazaro Quintela, Martín; Calvo Crespo, Patricia; Vázquez Estévez, Sergio; [et al.]

Maintenance treatment with cetuximab in a series of patients treated with standard chemotherapy and cetuximab in metastatic colorectal cancer

2011- Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; Quintero Aldana, Guillermo; Mel Lorenzo, José Ramón; [et al.]

Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer

2015- Gallardo Martín , Maria Elena; Fernández Montes, Ana; Varela Ferreiro, Silvia; Campos Balea, Begoña; Álvarez Gómez, Elena; [et al.]

Repositorio digital RUNA

Navegar por autor "Varela Ferreiro, Silvia"

Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study ﻿

Biweekly docetaxel-cisplatin in chemonaive patients with advanced epidermoid carcinoma of the lung - A phase II study of galician lung cancer group ﻿

Clinical and epidemiological characteristics of women with breast cancer and aromatase inhibitors treatment who presented hip fracture between 2008-2010 ﻿

Concurrent chemoradiation for stage III non-small cell lung cancer (NSCLC): A phase II study from the Galician lung cancer group ﻿

Docetaxel (D) and cisplatin (C) induction chemotherapy followed by biweekly D and C with concurrent thoracic radiotherapy for stage iii nonsmall cell lung cancer (NSCLC). A galician lung cancer group study. ﻿

Efficacy and safety of pemetrexed-cisplatin for advanced non-squamous non-small cell lung cancer - A galician lung cancer group study ﻿

Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO) ﻿

Erlotinib as frontline treatment for elderly patients (p) with advanced non-squamous non-small cell lung cancer (nsnsclc): ggcp044/09 study ﻿

Erlotinib as frontline treatment for elderly patients (P) with advanced non-squamous non-small cell lung cancer (NSNSCLC): GGCP044/09 study ﻿

Erlotinib as frontline treatment for elderly patients (p) with advanced nonsquamous non-small cell lung cancer (nsNSCLC): GGCP044/09 study ﻿

Erlotinib as frontline treatment for elderly patients with advanced non-small-cell lung cancer (NSCLC) and non-squamous histology - Results of a galician lung cancer group (GGCP044/09 study) grupo galego de cancro de pulmon (GGCP) ﻿

Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09) ﻿

Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention ﻿

Gemcitabine and Capecitabine as Third- or Later-line Therapy for Refractory Advanced Colorectal Cancer: A Retrospective Study ﻿

Gemcitabine Plus Oral Vinorelbine as Salvage Therapy Treatment for Patients With Advanced Non-small-cell Lung Cancer and Squamous Histology - a Galician Lung Cancer Group Study (GGCP042/09) Grupo Galego De Cancro De Pulmon (GGCP) ﻿

GGCP041/09: A GALICIAN STUDY OF SECOND-LINE ERLOTINIB IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC ﻿

GGCP041/09: A Galician study of second-line erlotinib in patients with advanced non-squamous non-small cell lung cancer (nsNSCLC) ﻿

Induction chemotherapy with docetaxel (D) and cisplatin (C) followed by concurrent thoracic radiotherapy with biweekly d and C for stage III non-small cell lung cancer (NSCLC) - A galician lung cancer group study ﻿

Maintenance treatment with cetuximab in a series of patients treated with standard chemotherapy and cetuximab in metastatic colorectal cancer ﻿

Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer ﻿

Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study

Biweekly docetaxel-cisplatin in chemonaive patients with advanced epidermoid carcinoma of the lung - A phase II study of galician lung cancer group

Clinical and epidemiological characteristics of women with breast cancer and aromatase inhibitors treatment who presented hip fracture between 2008-2010

Concurrent chemoradiation for stage III non-small cell lung cancer (NSCLC): A phase II study from the Galician lung cancer group

Docetaxel (D) and cisplatin (C) induction chemotherapy followed by biweekly D and C with concurrent thoracic radiotherapy for stage iii nonsmall cell lung cancer (NSCLC). A galician lung cancer group study.

Efficacy and safety of pemetrexed-cisplatin for advanced non-squamous non-small cell lung cancer - A galician lung cancer group study

Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)

Erlotinib as frontline treatment for elderly patients (p) with advanced non-squamous non-small cell lung cancer (nsnsclc): ggcp044/09 study

Erlotinib as frontline treatment for elderly patients (P) with advanced non-squamous non-small cell lung cancer (NSNSCLC): GGCP044/09 study

Erlotinib as frontline treatment for elderly patients (p) with advanced nonsquamous non-small cell lung cancer (nsNSCLC): GGCP044/09 study

Erlotinib as frontline treatment for elderly patients with advanced non-small-cell lung cancer (NSCLC) and non-squamous histology - Results of a galician lung cancer group (GGCP044/09 study) grupo galego de cancro de pulmon (GGCP)

Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)

Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention

Gemcitabine and Capecitabine as Third- or Later-line Therapy for Refractory Advanced Colorectal Cancer: A Retrospective Study

Gemcitabine Plus Oral Vinorelbine as Salvage Therapy Treatment for Patients With Advanced Non-small-cell Lung Cancer and Squamous Histology - a Galician Lung Cancer Group Study (GGCP042/09) Grupo Galego De Cancro De Pulmon (GGCP)

GGCP041/09: A GALICIAN STUDY OF SECOND-LINE ERLOTINIB IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC

GGCP041/09: A Galician study of second-line erlotinib in patients with advanced non-squamous non-small cell lung cancer (nsNSCLC)

Induction chemotherapy with docetaxel (D) and cisplatin (C) followed by concurrent thoracic radiotherapy with biweekly d and C for stage III non-small cell lung cancer (NSCLC) - A galician lung cancer group study

Maintenance treatment with cetuximab in a series of patients treated with standard chemotherapy and cetuximab in metastatic colorectal cancer

Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer